Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
JACC. Cardiooncology|January 17, 2026
Pretreatment Circulating Vascular Biomarkers Predict Cancer Therapy-Related Cardiac Dysfunction During HER2+ Breast Cancer TreatmentDakota Gustafson, Priya Mistry, Crizza Ching, et al.
Radiology. Cardiothoracic Imaging|March 29, 2023
Myocardial Inflammation on FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 VaccinationConstantin Arndt Marschner, Paaladinesh Thavendiranathan, Dakota Gustafson, et al.
Biomaterials|January 14, 2020
Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testingOlya Mastikhina, Byeong-Ui Moon, Kenneth Williams, et al.
The Journal of Biological Chemistry|April 22, 2006
c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytesNorbert Degousee, Denis Angoulvant, Shafie Fazel, et al.
Aging Cell|January 22, 2020
Cellular senescence contributes to age-dependent changes in circulating extracellular vesicle cargo and functionFaisal J Alibhai, Fievel Lim, Azadeh Yeganeh, et al.
EMBO Molecular Medicine|February 18, 2026
KRAS-dependent glycolytic reprogramming of endothelial cells in sporadic arteriovenous malformationsRuilin Wu, Negar Khosraviani, Ann Mansur, et al.
Genome Medicine|May 1, 2026
ERG is a regulator of dynamic and reversible endothelial plasticityKristen Schulz, Steven R Botts, Kai Ellis, et al.
Journal of Molecular and Cellular Cardiology Plus|June 9, 2025
Glyoxal is a superior fixative to formaldehyde in promoting antigenicity and structural integrity in murine cardiac tissuesAllen C T Teng, Dev Mehangrey, Ava Vandenbelt, et al.
Developmental Cell|July 9, 2013
ETS factors regulate Vegf-dependent arterial specificationJoshua D Wythe, Lan T H Dang, W Patrick Devine, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
MEK signaling represents a viable therapeutic vulnerability of KRAS-driven somatic brain arteriovenous malformationsCarlos Flores Suarez, Omar Ashraf Harb, Ariadna Robledo, et al.
Pageof 9